PATENT CLAIM ANALYSIS

Application Number: 15938380
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["435", "252300"]

Abstract:
Genetically engineered cells and methods are presented that allow for the production of various value products from CO 2 . Contemplated cells have a CBB cycle that is genetically modified such that two molecules of CO 2  fixed in the CBB cycle can be withdrawn from the modified CBB cycle as a single C2 compound. In contemplated aspects a CBB cycle includes an enzymatic activity that generates the single C2 compound from a compound of the CBB cycle, while further modifications to the CBB cycle will not introduce additional recombinant enzymatic activity/activities outside the already existing catalytic activities in the CBB cycle.

Claim (Index 2):
The metabolically engineered cell of  claim 1 , wherein the cell is a bacterial cell.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 90.0
- Lexical Diversity: 1.64062
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15115670', '14187465', '15336744', '14853946', '14211415']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6435271443578838
- 35 USC 102 Novelty (BERT): 0.5759697625691487
- Combined Prediction Score: 0.6367714061790103
- Mean Citation Score: 322.9536480000001
- Max Citation Score: 520.89703
- Similarity Product: 378.4601500388932

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test